Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 07, 2023, titled "Zydus receives finalapproval from the USFDA for Lenalidomide Capsules, 2.5 mg and 20 mg".
Press Release Mar 07 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Mar 03 2023
- Press Release Mar 02 2023
- Press Release Feb 28 2023
- Press Release Feb 24 2023
- Press Release Feb 20 2023
Later from Zydus Lifesciences
- Press Release Mar 09 2023
- Zydus Lifesciences Limited Press Release Mar 15 2023
- Press Release Mar 21 2023
- Press Release Mar 24 2023
- Press Release Mar 25 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences